Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 avr. 2024 16h11 HE | Source: Robbins LLP

VTYX Stockholders are Encouraged to Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Ventyx Biosciences, Inc. Class Action

Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug
26 mars 2024 00h27 HE | Source: Robbins LLP

VTYX Stockholders with Large Losses Should Contact Robbins LLP to Learn More about the Ventyx Biosciences, Inc. Class Action

Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug
14 mars 2024 00h01 HE | Source: Robbins LLP

VTYX STOCKHOLDER NEWS: Contact Robbins LLP for Information Regarding the Ventyx Biosciences, Inc. Class Action

Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug
04 mars 2024 17h33 HE | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Ventyx Biosciences, Inc. (VTYX)

Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug